Chapter 37 - Neurologic manifestations of inherited disorders of connective tissue
Introduction
Inherited disorders of connective tissue are monogenic diseases that affect the structure or function of the connective tissue. While these disorders are transmitted within families according to a Mendelian inheritance pattern, de novo mutations are common and a substantial proportion of patients do not have any family history of the disease. Although neurologic manifestations are often not part of the major diagnostic criteria, they represent classic and potentially severe complications of many inherited connective tissue disorders. For the neurologist, being aware of the main characteristics and diagnostic criteria of these disorders is important for two reasons: (1) in some cases neurologic complications can be the first manifestation of the disease, and (2) special caution may be required for the management of these patients, especially with regards to invasive exams or procedures and antithrombotic therapy. In the first part of this chapter we describe the most common neurologic manifestations of inherited disorders of connective tissue in adults. The second part reviews the main diagnostic and therapeutic implications of these disorders for the practicing neurologist.
Section snippets
Neurologic manifestations of the most common inherited disorders of connective tissue
Inherited disorders of connective tissue leading to neurologic complications are summarized in Table 37.1. The majority of neurologic manifestations are cerebrovascular, mostly due to alterations in the vascular connective tissue. Other neurologic manifestations are mostly secondary to osteoarticular complications.
Conclusions
For the neurologist, being aware of heritable connective tissue disorders and their neurologic complications is particularly important in the following situations:
References (83)
- et al.
White matter lesions leading to the diagnosis of pseudoxanthoma elasticum
Rev Neurol (Paris)
(2010) - et al.
Cervical-artery dissections: predisposing factors diagnosis and outcome
Lancet Neurol
(2009) - et al.
Effect of mutation type and location on clinical outcome in 1013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study
Am J Hum Genet
(2007) - et al.
Peripheral neuropathy in Ehlers–Danlos syndrome
Pediatr Neurol
(1995) - et al.
Marfan’s syndrome
Lancet
(2005) - et al.
Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers–Danlos syndrome: a prospective randomised open blinded-endpoints trial
Lancet
(2010) - et al.
Clinical features and differential diagnosis of aortic dissection: experience with 236 cases (1980 through 1990)
Mayo Clin Proc
(1993) - et al.
Pseudoxanthoma elasticum: molecular genetics and putative pathomechanisms
J Invest Dermatol
(2010) - et al.
Haploinsufficiency of TNXB is associated with hypermobility type of Ehlers–Danlos syndrome
Am J Hum Genet
(2003) - et al.
Vertebral artery dissection: presenting findings and predictors of outcome
Stroke
(2006)